Sensi Products, a California-based cannabis company, has been granted temporary licenses by the state to continue production and distribution within the recreational market. Sensi Products recently teamed up with the Institute for Research of Cannabis (IROC) for a 1,400 person study examining cannabis’s role in the treatment of sleep disorders, anxiety, pain, and PTSD. Sensi’s study is the largest medically peer-reviewed study of its kind, and findings are set to be announced at a psychological conference next quarter. CannEpoch will report the results as soon as they’re released.
